Document is current
Any future updates will be listed below
-
Authors
Birk, Sebastian https://orcid.org/0009-0005-8854-177X
Bonafonte-Pardàs, Irene
Feriz, Adib Miraki
Boxall, Adam https://orcid.org/0000-0002-3677-3043
Agirre, Eneritz https://orcid.org/0000-0002-5012-0305
Memi, Fani
Maguza, Anna
Yadav, Anamika
Armingol, Erick https://orcid.org/0000-0002-1546-9165
Fan, Rong https://orcid.org/0000-0001-7805-8059
Castelo-Branco, Gonçalo https://orcid.org/0000-0003-2247-9393
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Bayraktar, Omer Ali https://orcid.org/0000-0001-6055-277X
Talavera-López, Carlos https://orcid.org/0000-0001-8590-2393
Lotfollahi, Mohammad https://orcid.org/0000-0001-6858-7985
- License Information
-
More Information
Article History
Received: 21 March 2024
Accepted: 5 February 2025
First Online: 18 March 2025
Competing interests
: S.B. is a part-time employee at Avanade Deutschland. M.L. owns interests in Relation Therapeutics and is a scientific cofounder and part-time employee at AIVIVO. F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd. and Omniscope and has an ownership interest in Dermagnostix GmbH and Cellarity. As of 1 February, 2025, C.T-L. is an employee at Cellzome GmbH/GSK. His contributions were done while being at the University of Würzburg. The other authors declare no competing interests.
